Therapeutic compounds for pain and synthesis thereof

Patent metadata

Field	Value
Publication number	US-10040795-B2
Application number	US-201615254938-A
Country	US
Kind code	B2
Filing date	Sep 1, 2016
Priority date	Sep 4, 2015
Publication date	Aug 7, 2018
Grant date	Aug 7, 2018

Abstract

The invention provides compounds of Formula 1:

and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

First claim

What is claimed is:

1. A compound of Formula 1:

or a stereoisomer, pharmaceutically acceptable salt, or mixture thereof.

2. The compound of claim 1 , wherein Formula 1 is:

or a stereoisomer, pharmaceutically acceptable salt, or mixture thereof.

3. A pharmaceutical composition comprising a compound of claim 2 , and a pharmaceutically acceptable carrier or diluent.

4. A method for treating pain in a subject in need comprising administering to the subject an effective amount of the compound of claim 2 .

5. The method of claim 4 , wherein the compound is administered to effect localized delivery to the subject.

6. The method of claim 4 , wherein the compound is administered to effect systemic delivery to the subject.

7. The method of claim 4 , wherein the pain is neuropathic pain or chronic pain.

8. A method of making a compound of Formula 1:

comprising reacting a compound of Formula 2:

with cyclopropylcarboxaldehyde in the presence of a reducing agent.

9. The method of claim 8 , wherein the cyclopropylcarboxaldehyde was added before the reducing agent.

10. The method of claim 8 , wherein the reducing agent is sodium triacetoxyborohydride.

11. The method of claim 8 , wherein the compound of Formula 1 is chirally separated.

12. The method of claim 8 , further comprising making the compound of Formula 2 by reacting a compound of Formula 3:

with an acid.

13. The method of claim 12 , wherein the acid is trifluoroacetic acid.

14. The method of claim 12 , further comprising:
making the compound of Formula 3 by reacting a compound of Formula 4:

with dimethylaminopyridine;
making the compound of Formula 4 by reacting a compound of Formula 5:

with tert-butyldiphenylchlorosilane;
making the compound of Formula 5 by reacting a compound of Formula 6.b:

with 3,3,3-trifluoropropanoic acid;
making the compound of Formula 6.b by chirally separating a compound of Formula 7:

making the compound of Formula 7 by reacting a compound of Formula 8:

with hydrogen in the presence of a catalyst;
making the compound of Formula 8 by reacting a compound of Formula 9:

with Boc 2 O;
making the compound of Formula 9 by reacting a compound of Formula 10:

with iodotrimethylsilane;
making the compound of Formula 10 by reacting a compound of Formula 11:

with tert-butyldiphenylchlorosilane;
making the compound of Formula 11 by reacting compounds of Formula 12:

and Formula 12.a:

with benzaldehyde in a solvent;
making the compound of Formula 12 and Formula 12.a by reacting a compound of Formula 13:

with hydrogen in the presence of a catalyst;
making the compound of Formula 13 by reacting a compound of Formula 14:

with potassium cyanide;
making the compound of Formula 14 by reacting a compound of Formula 15:

with mesyl chloride;
making the compound of Formula 15 by reacting a compound of Formula 16:

with a reducing agent;
making the compound of Formula 16 by reacting a compound of Formula 17:

with ethyl chloroformate;
making the compound of Formula 17 by reacting a compound of Formula 18:

with benzoic acid in the presence of an activating agent; and
making the compound of Formula 18 by reacting a compound of Formula 19:

with a reducing agent.

15. The method of claim 14 , wherein
the step of making of the compound of Formula 4 further comprises pyridine;
the step of making of the compound of Formula 5 further comprises N—N-Diisopropylethylamine;
the catalyst in the step of making the compound of Formula 7 comprises palladium;
the step of making of the compound of Formula 8 further comprises triethylamine (Et 3 N);
the step of method of making a compound of Formula 9 takes place at a temperature above 60° C.;
the step of making a compound of Formula 10 further comprises imidazole;
the step of making a compound of Formula 11 further comprises sodium triacetoxyborohydride and the solvent is ethanol; and
the catalyst in the step of making a compound of Formula 12.a is Raney-nickel.

16. The method of claim 14 , wherein the making of the compound of Formula 5 further comprises (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) sodium triacetoxyborohydride.

17. The method of claim 14 , wherein the catalyst in the step of making the compound of Formula 7 is palladium on carbon.

18. The method of claim 14 , wherein
the step of making a compound of Formula 13 further comprises 18-crown-6;
the step of making a compound of Formula 14 further comprises triethylamine;
the reducing agent in the step of making a compound of Formula 15 is sodium borohydride;
the step of making a compound of Formula 16 further comprises a base;
the activating agent in step of making a compound of Formula 17 is diethylazodicaroxylate with triphenylphosphine or diisopropyl azodicarboxylate with triphenylphosphine; and
the reducing agent in the step of making a compound of Formula 18 is sodium borohydride.

19. The method of claim 18 , wherein the base in the making of a compound of Formula 16 is potassium carbonate.

Assignees

• Janssen Pharmaceutica Nv

Inventors

• Decorte Bart
• Russcher Jacob Cornelis
• Monnee Menno Cornelis Franciscus

Classifications

• A61P29/02

  without antiinflammatory effect · CPC title

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• A61P25/04

  Centrally acting analgesics, e.g. opioids · CPC title

• A61P25/02

  for peripheral neuropathies · CPC title

• C07D451/10

  acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine · CPC title